Currently, BOTOX® is approved by the U.S. Food and Drug Administration (FDA) only to treat migraines in adults. One in 10 school-aged children and teens suffer from migraines, but there are few FDA-approved medications for this age group. Injections of botulinum toxin (BOTOX®) may provide significant relief from hard-to-treat migraines, suggests a small preliminary study presented at the ANESTHESIOLOGY 2017 annual meeting.